Biotech Sector Snapshot
Long Only, Biotech
Seeking Alpha Analyst Since 2009
Founder of 500+ member ROTY Biotech Community (try the 2-week free trial to see if it adds value for you). Quality over quantity- enjoy connecting with readers.
Daily Advanced Chart
Easier returns came in 2019 and 2020 (XBI up 32% and 48%).
With record levels of investment in biotech sector last year, wouldn't be surprised to see consolidation in current range for a while and increased volatility.
In the event of a correction, we've observed that companies with strongest near term clinical momentum and catalyst pipeline are often the ones to bounce back quickest when the smoke clears.
High degree of derisking (via POC data sets, straightforward MOA, multiple irons in the fire, lucrative partnerships, etc) is imperative to avoid big binary losses that are hard to come back from.
Stick to highest conviction setups, avoid mediocre ideas or trading just for the sake of doing something. Cash is our friend, to hold and wait patiently for optimal situations where risk/reward heavily slanted in your favor.
Just my two cents as always.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.